These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23432431)
1. Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia. Mohr B; Schetelig J; Schäfer-Eckart K; Schmitz N; Hänel M; Rösler W; Frickhofen N; Link H; Neubauer A; Schuler U; Platzbecker U; Middeke JM; Ehninger G; Bornhäuser M; Schaich M; Stölzel F; Br J Haematol; 2013 Apr; 161(2):237-44. PubMed ID: 23432431 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Abnormalities of the Short Arm of Chromosome 17. Mori J; Yanada M; Uchida N; Fukuda T; Sakura T; Hidaka M; Watakabe-Inamoto K; Kanamori H; Ogawa H; Ichinohe T; Tanaka J; Atsuta Y; Yano S Biol Blood Marrow Transplant; 2017 Aug; 23(8):1398-1404. PubMed ID: 28455005 [TBL] [Abstract][Full Text] [Related]
3. Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-. Middeke JM; Beelen D; Stadler M; Göhring G; Schlegelberger B; Baurmann H; Bug G; Bellos F; Mohr B; Buchholz S; Schwerdtfeger R; Martin H; Hegenbart U; Ehninger G; Bornhäuser M; Schetelig J; Blood; 2012 Sep; 120(12):2521-8. PubMed ID: 22855604 [TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Middeke JM; Fang M; Cornelissen JJ; Mohr B; Appelbaum FR; Stadler M; Sanz J; Baurmann H; Bug G; Schäfer-Eckart K; Hegenbart U; Bochtler T; Röllig C; Stölzel F; Walter RB; Ehninger G; Bornhäuser M; Löwenberg B; Schetelig J Blood; 2014 May; 123(19):2960-7. PubMed ID: 24652988 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265 [TBL] [Abstract][Full Text] [Related]
6. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895 [TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454 [TBL] [Abstract][Full Text] [Related]
8. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial. Pfirrmann M; Ehninger G; Thiede C; Bornhäuser M; Kramer M; Röllig C; Hasford J; Schaich M; Lancet Oncol; 2012 Feb; 13(2):207-14. PubMed ID: 22197676 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B J Clin Oncol; 2012 Jun; 30(17):2140-6. PubMed ID: 22564995 [TBL] [Abstract][Full Text] [Related]
10. Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study. Schmid C; Schleuning M; Tischer J; Holler E; Haude KH; Braess J; Haferlach C; Baurmann H; Oruzio D; Hahn J; Spiekermann K; Schlimok G; Schwerdtfeger R; Buechner T; Hiddemann W; Kolb HJ Bone Marrow Transplant; 2012 Jan; 47(1):46-53. PubMed ID: 21358688 [TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients. Jackson K; Kennedy G; Mollee P; Marlton P; Morris K Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966 [TBL] [Abstract][Full Text] [Related]
12. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment. Shin HJ; Kim HJ; Sohn SK; Min YH; Won JH; Kim I; Yoon HJ; Lee JH; Jo DY; Joo YD; Jung CW; Lee KH; ; Chung JS; Ahn JS; Kim SJ; Lee JH; Choi SJ; Lee JH; Bae SH; Hong DS; Zang DY; Kim SH; Lee JL; Bang SM Jpn J Clin Oncol; 2010 Jun; 40(6):556-66. PubMed ID: 20185460 [TBL] [Abstract][Full Text] [Related]
13. Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation. Lee JW; Jang PS; Chung NG; Cho B; Kim HK Br J Haematol; 2013 Jan; 160(1):80-6. PubMed ID: 23106148 [TBL] [Abstract][Full Text] [Related]
14. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation? Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098 [TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine. Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990 [TBL] [Abstract][Full Text] [Related]
16. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656 [TBL] [Abstract][Full Text] [Related]